Q2 2026 Getinge publ AB Earnings Call Transcript
Hi, everyone, and welcome to today's conference call. With me today, I have Agneta Palmer, our CFO. And in today's conference, we'll go through our performance and some highlights for the second quarter before opening up for Q&A. So we can move over to page number two, please.
And as usual, let's start by looking at the development of our strategic KPIs. We continue to clearly track in line with plan to increase the share of sales from recurring revenue, accelerating the share of sales from high-end margin products like, for example, our ECLS offering, consumables in infection control and beta bags in sterile transfer.
This is all supported by solid and effective quality processes, and sales from recurring revenue continue to make up about two-thirds, and high-margin products are now at 70%. For quality, the number of field actions in relation to sales has decreased significantly, and we're pacing a lot better than last year. These improvements should, of course, be achieved through a responsible leverage
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
